United Kingdom - English - myHealthbox

zentiva - atorvastatin - film-coated tablets - 80mg - lipid modifying agents - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

United Kingdom - English - myHealthbox

zentiva - atorvastatin - film-coated tablets - 40mg - lipid modifying agents - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

United Kingdom - English - myHealthbox

caduceus pharma ltd - atorvastatin - film-coated tablets - 10mg - lipid modifying agents, hmg-coa-reductase inhibitors - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults adolescents and children aged 10 years or older or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

United Kingdom - English - myHealthbox

caduceus pharma ltd - atorvastatin - film-coated tablets - 20mg - lipid modifying agents, hmg-coa-reductase inhibitors, - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults adolescents and children aged 10 years or older or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

United Kingdom - English - myHealthbox

caduceus pharma ltd - atorvastatin - film-coated tablets - 40mg - lipid modifying agents, hmg-coa-reductase inhibitors - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - atorvastatin calcium trihydrate - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - atorvastatin calcium trihydrate - oral tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - atorvastatin calcium trihydrate - oral tablet - 40mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - atorvastatin calcium trihydrate - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - atorvastatin calcium trihydrate - oral tablet - 10mg